Related Experiment Video
Updated: May 5, 2026
COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
The Shifting Landscape of HIV-Tuberculosis Co-Infection in the MENA Region with a Focus on Saudi Arabia: A Systematic
Zikria Saleem1, Masaad Saeed Almutairi2, Huda Arooj3
1Department of Pharmacy Practice, College of Pharmacy, Qassim University, Buraydah, Saudi Arabia.
Introduction:
The interaction between human immunodeficiency virus (HIV) and tuberculosis (TB) presents a persistent public health challenge, particularly with the emergence of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB). The Middle East and North Africa (MENA) region shows complex TB patterns, and Saudi Arabia continues to face challenges in TB control within the regional context.
Methods:
Using Global Burden of Disease (GBD) 2023 estimates, we analyzed age-standardized disability-adjusted life year (DALY) and incidence trends for HIV and drug-susceptible TB, MDR-TB, and XDR-TB in Saudi Arabia and the MENA region from 1990 to 2023. Temporal patterns were quantified using Joinpoint regression to estimate annual percent change (APC) and average annual percent change (AAPC).
Results:
Across MENA and Saudi Arabia, the burden of drug-susceptible TB increased during the 1990s to early 2000s and subsequently declined in 2023 (MENA age-standardized DALY rate [ASDR]: 6.60 in 1990, peaking at 13.11 in 1999, declining to 7.39 in 2023; Saudi Arabia ASDR: 13.63 in 1990, peaking at 20.56 in 2003, declining to 4.94 in 2023). A similar temporal pattern was observed for MDR-TB (MENA ASDR (Age-Standardized DALY Rate): 0.03 in 1990, peaking at 1.04 in 2002, declining to 0.40 in 2023; Saudi Arabia ASDR: 0.03 in 1990, peaking at 1.93 in 2003, declining to 0.33 in 2023). In contrast, XDR-TB showed an overall decline in MENA (ASDR: 1.72 in 1991, declining to 0.02 in 2023), while in Saudi Arabia, ASDR declined from 2.42 in 1991 to 0.02 in 2023. MENA estimates are presented to provide regional context and enable comparison with national trends in Saudi Arabia.
Conclusions:
From 1990 to 2023, the TB burden among people with HIV in Saudi Arabia declined substantially, particularly for drug-susceptible TB, indicating progress in TB control and HIV management. Drug-resistant forms (MDR-TB and XDR-TB) showed complex trends with early increases followed by stabilization or gradual reductions in absolute burden.
More Related Videos
09:02An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 17, 2014
23:56Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Related Concept Videos
01:31Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:26Sexually Transmitted Infections
01:26Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Infectious Diseases and Their Occurrence